A Comparative Study of Immunogenicity, Antibody Persistence, and Safety of Three Different COVID-19 Boosters between Individuals with Comorbidities and the Normal Population

Data on immunogenicity, immune response persistency, and safety of COVID-19 boosters in patients with comorbidities are limited. Therefore, we aimed to evaluate three different boosters’ immunogenicity and safety in individuals with at least one underlying disease (UD) (obesity, hypertension, and di...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashrafian, Fatemeh, Bagheri Amiri, Fahimeh, Bavand, Anahita, Zali, Mahsan, Sadat Larijani, Mona, Ramezani, Amitis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459403/
https://www.ncbi.nlm.nih.gov/pubmed/37631944
http://dx.doi.org/10.3390/vaccines11081376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459403/
https://www.ncbi.nlm.nih.gov/pubmed/37631944
http://dx.doi.org/10.3390/vaccines11081376

Ejemplares similares